Results for tag: "Scleroderma"

Scleroderma is a chronic skin condition that affects the connective tissue of the skin and other organs. It is characterized by hardening and thickening of the skin, as well as joint pain and stiffness. It can also cause damage to the lungs, heart, and kidneys. Treatment for scleroderma includes medications, physical therapy, and lifestyle changes. The scleroderma market within the context of dermatology is a growing one, with a focus on developing treatments that can improve the quality of life for those affected. There is a need for more effective treatments, as well as better diagnosis and management of the condition. Some companies in the scleroderma market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more